Heart Beat: May 2018

The bacterium Chlamydia pneumonia is known to be present in atherosclerotic plaques, and macrolide antibiotics will eradicate C. pneumoniae from atherosclerosis. Two studies have shown this improves the cardiovascular health of patients with coronary artery disease (CAD), likely by reducing inflammation.
To continue reading this article you must be a paid subscriber

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!


Please enter your comment!
Please enter your name here